Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.090
+0.110 (5.56%)
At close: Jan 2, 2026, 4:00 PM EST
2.088
-0.002 (-0.12%)
After-hours: Jan 2, 2026, 7:59 PM EST
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $100.96 million as of January 2, 2026. Its market cap has decreased by -21.11% in one year.
Market Cap
100.96M
Enterprise Value
-5.12M
1-Year Change
-21.11%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $100.96M, a decrease of -52.51%. That is a compound annual growth rate of -2.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 100.96M | 5.56% |
| Dec 31, 2025 | 95.65M | -15.76% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |